Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Plos One|July 22, 2016
Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve CareJessica E Martin, Joel Raffel, Richard Nicholas
Archives of Neurology|February 15, 2012
Vitamin B(12) deficiency with bilateral globus pallidus abnormalitiesAnjail Z Sharrief, Joel Raffel, David S Zee
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2018
Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trialsRichard S Nicholas, Erika Han, Joel Raffel, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Multiple sclerosis therapy and Epstein-Barr virus antibody titresJoel Raffel, Ruth Dobson, Arie Gafson, et al.
Plos Medicine|July 11, 2017
Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29Joel Raffel, Alison Wallace, Djordje Gveric, et al.
Plos One|January 13, 2017
Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple SclerosisJoel Raffel, Arie R Gafson, Samer Dahdaleh, et al.
The European Journal of Neuroscience|March 24, 2009
Induction and expression of GluA1 (GluR-A)-independent LTP in the hippocampusCarola Romberg, Joel Raffel, Lucy Martin, et al.
Molecular Imaging and Biology|February 24, 2019
Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey MatterSujata Sridharan, Joel Raffel, Ashwini Nandoskar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 12, 2014
Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosisSandra Amor, Baukje J van der Star, Isabel Bosca, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2016
Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brainClaire Feeney, Gregory Scott, Joel Raffel, et al.
Pageof 2